As of 2025-07-04, the Intrinsic Value of Bioquest Corp (BQST) is -0.22 USD. This BQST valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.60 USD, the upside of Bioquest Corp is -136.24%.
Based on its market price of 0.60 USD and our intrinsic valuation, Bioquest Corp (BQST) is overvalued by 136.24%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.22 - -0.22 | -0.22 | -136.24% |
| P/E | (0.01) - (0.02) | (0.02) | -102.9% |
| DDM - Stable | (0.84) - (41.85) | (21.34) | -3645.3% |
| DDM - Multi | (1.33) - (51.15) | (2.58) | -528.5% |
| Market Cap (mil) | 7.04 |
| Beta | 49.23 |
| Outstanding shares (mil) | 11.69 |
| Enterprise Value (mil) | 7.21 |
| Market risk premium | 4.60% |
| Cost of Equity | 5.87% |
| Cost of Debt | 5.00% |
| WACC | 5.81% |